Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for prevention and treatment of oxaliplatin-induced peripheral neuropathy in gastrointestinal cancer
IRCT20160920029889N5Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of venlafaxine in peripheral neuropathy, sponsored by Urmia University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
venlafaxine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on IRCT20160920029889N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160920029889N5.